Expression of CCR5 associated with HER2 in circulating tumor cells (CTCs) is a novel biomarker for patients with metastatic breast cancer (MBC)

被引：2
|
作者：
Zhang, Qiang [1 ]
Gerratana, Lorezo [2 ,3 ]
Shah, Ami N. [2 ]
Davis, Andrew A. [2 ]
Flaum, Lisa [2 ]
Zhang, Youbin [2 ]
Pestell, Richard G. [4 ]
Wehbe, Firas [2 ]
Behdad, Amir [2 ]
Platanias, Leonidas [1 ]
Gradishar, William [1 ]
Cristofanilli, Massimo [1 ]
机构：
[1] Northwestern Univ, Lurie Canc Ctr, Chicago, IL 60611 USA
[2] Northwestern Univ, Chicago, IL 60611 USA
[3] Univ Udine, Udine, Italy
[4] Penn Biotechnol Ctr, Baruch S Blumberg Inst, Penn Canc & Regenerat Med Res Ctr, Wynnewood, IL USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-408
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
408
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Increased chromatin heterogeneity in circulating tumor cells (CTCs) is associated with high levels of HER2 expression in metastatic breast cancer (MBC)
    Zhang, Qiang
    Gerratana, Lorenzo
    Shah, Ami N.
    Davis, Andrew Adam
    Flaum, Lisa
    Zhou, Xiang
    Zhang, Youbin
    Backman, Vadim
    Behdad, Amir
    Wehbe, Firas
    Gradishar, William
    Platanias, Leonidas
    Cristofanilli, Massimo
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [2] HER2, AR protein expression and chromosomal instability in circulating tumor cells (CTCs) of metastatic breast cancer (MBC) patients (pts)
    Ontiveros, Priscilla
    Landaverde, Connie
    Levin, Maren K.
    Hippely, Sarah
    Landers, Mark
    Wang, Yipeng
    Dittamore, Ryan
    O'Shaughnessy, Joyce A.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [3] Multiple Biomarker Expression in Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer (MBC) Patients (Pts).
    Somlo, G.
    Hsieh, H. B.
    Curry, D. N.
    Frankel, P.
    Krivacic, R. T.
    Lau, S.
    Lazarus, N.
    Baker, N.
    Swain-Cabriales, S.
    Bruce, R.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 649S - 649S
  • [4] Enabling HER2 and androgen receptor (AR) protein expression and localization in circulating tumor cells (CTCs) of ER(+/-)HER2(-) metastatic breast cancer (MBC) patients (pts)
    Ontiveros, P.
    Landaverde, C.
    Graf, R.
    Levin, M. K.
    Hippely, S.
    Wang, Y.
    Landers, M.
    Dittamore, R.
    O'Shaughnessy, J. A.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [5] FLUCTUATION OF HER2/NEU PROTEIN LEVELS IN CIRCULATING TUMOR CELLS (CTCS) FROM METASTATIC BREAST CANCER (MBC) PATIENTS (PTS)
    Bessi, S.
    Galardi, F.
    Truglia, M. C.
    Pestrin, M.
    Chiarelli, C.
    Cappadona, S.
    Licitra, S.
    Biganzoli, L.
    Giannini, A.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 50 - 50
  • [6] Expression of truncated HER2 receptor in circulating tumor cells (CTCs) of breast cancer patients
    Kallergi, Galaktia
    Nasias, Dimitris
    Papadaki, Maria A.
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Agelaki, Sophia
    [J]. CANCER RESEARCH, 2012, 72
  • [7] Truncated HER2 receptor in circulating tumor cells (CTCs) of early and metastatic breast cancer patients
    Kallergi, G.
    Nasias, D.
    Papadaki, M.
    Mavroudis, D.
    Georgoulias, V.
    Agelaki, S.
    [J]. CANCER RESEARCH, 2012, 72
  • [8] Circulating tumor cells (CTCs) biomarker evaluation from patients with metastatic breast cancer (MBC) utilizing the TargetSelector™ platform
    Hamilton, E. P.
    Yardley, D. A.
    Burris, H. A., III
    Shastry, M.
    Huynh, L.
    Bhikha, L.
    Singh, V. M.
    [J]. CANCER RESEARCH, 2017, 77
  • [9] Circulating tumor cells (CTCs) detect HER2+status and phenotypic heterogeneity in metastatic breast cancer (MBC)
    Austin, Laura
    Mu, Zhaomei
    Avery, Tiffany
    Jaslow, Rebecca
    Paolillo, Carmela
    Toss, Angela
    Fortuna, Paolo
    Zhong, Ye
    Yang, Hushan
    Cristofanilli, Massimo
    [J]. CANCER RESEARCH, 2015, 75
  • [10] Distribution and prognostic role of HER2 status of circulating tumor cells (CTCs) and tumor-derived extracellular vesicles (tdEVs) in HER2-metastatic breast cancer (MBC) patients (pts)
    Nicolo, E.
    Munoz-Arcos, L.
    D'Amico, P.
    Zhang, Y.
    Gerratana, L.
    Serafini, M.
    Pontolillo, L.
    Strickland, K.
    Manai, M.
    Davis, A. A.
    Donahue, J.
    Liu, H.
    Gradishar, W. J.
    Shah, A. N.
    Curigliano, G.
    Reduzzi, C.
    Cristofanilli, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S363 - S363
12345